Candel Therapeutics

IPO

Pioneering Precision Viral Immunotherapy for Patients Fighting Solid Tumors

Public · Needham, United States · Founded 2020 · $180.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$180.0M
Last Round
$100.0M Venture RoundFeb 2026
Rounds
3
Type
Public

About

Candel Therapeutics is a clinical-stage biopharmaceutical company developing off-the-shelf multimodal viral immunotherapies for solid tumors. Its platforms are designed to cause in-situ immunization by inducing tumor cell lysis and stimulating both innate and adaptive immune responses. Candel's investigational therapies target durable clinical benefit across multiple cancer indications, including prostate cancer, lung cancer, and glioblastoma.

Summary

Candel Therapeutics is a Biotech company based in Needham, United States, founded in 2020. It has raised $180.0M in total across 3 rounds, most recently a $100.0M Venture Round round in Feb 2026. Investors include Trinity Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundFeb 2026
$100.0M

Sign up to see all 5 rounds

Venture Round through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Candel Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/candel-therapeutics"><img src="https://indexed.vc/api/badge/company/candel-therapeutics" alt="Candel Therapeutics on Indexed.vc" width="260" height="76" /></a>